CESTAT determined classification of imported glucose monitoring...

CESTAT determined classification of imported glucose monitoring devices under CTH 9027 80 90, affirming prior judicial precedents from Bayer Pharmaceuticals case and Bombay HC ruling. The tribunal upheld classification under scientific instrument heading, which qualifies for NIL Basic Customs Duty (BCD) under Notification No. 24/2005-Cus. The revenue's appeal was dismissed, confirming the concessional duty rate for goods classified under CTH 9027, distinguishing them from medical instruments under CTH 9018. The decision reinforces the specific tariff classification principles for medical diagnostic equipment, granting the appellant the benefit of zero customs duty based on the precise product categorization.

---